Xianglin Hao

502 total citations
22 papers, 315 citations indexed

About

Xianglin Hao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xianglin Hao has authored 22 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Xianglin Hao's work include RNA modifications and cancer (8 papers), Cancer-related gene regulation (6 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). Xianglin Hao is often cited by papers focused on RNA modifications and cancer (8 papers), Cancer-related gene regulation (6 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). Xianglin Hao collaborates with scholars based in China, Denmark and United States. Xianglin Hao's co-authors include Fei Han, Jinyi Liu, Lin Ao, Xiao Jiang, Jia Cao, Wenbin Liu, Huidong Zhang, Zhi Wang, Rong Wang and Weiping Wang and has published in prestigious journals such as Cell Death and Differentiation, Cell Death and Disease and Toxicology.

In The Last Decade

Xianglin Hao

20 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianglin Hao China 12 222 101 67 39 27 22 315
Akira Nagaoka Japan 9 262 1.2× 103 1.0× 58 0.9× 44 1.1× 18 0.7× 24 364
Julie Di Bernardo United States 12 327 1.5× 133 1.3× 59 0.9× 40 1.0× 15 0.6× 15 487
Tina Fuglsang Daugaard Denmark 10 184 0.8× 45 0.4× 45 0.7× 37 0.9× 22 0.8× 20 241
Yang Cheng China 10 161 0.7× 74 0.7× 33 0.5× 47 1.2× 39 1.4× 29 331
Halfdan Rydbeck Norway 9 197 0.9× 94 0.9× 71 1.1× 49 1.3× 47 1.7× 14 317
Cai Lv China 9 164 0.7× 89 0.9× 118 1.8× 61 1.6× 27 1.0× 20 304
Simran Arora United States 6 407 1.8× 308 3.0× 43 0.6× 27 0.7× 17 0.6× 11 540
Joseph Nariculam United Kingdom 9 338 1.5× 68 0.7× 116 1.7× 67 1.7× 24 0.9× 14 504
Iyare Izevbaye Canada 9 70 0.3× 62 0.6× 50 0.7× 65 1.7× 28 1.0× 23 244
Yong Qiu Doughman United States 9 274 1.2× 28 0.3× 66 1.0× 37 0.9× 63 2.3× 10 386

Countries citing papers authored by Xianglin Hao

Since Specialization
Citations

This map shows the geographic impact of Xianglin Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianglin Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianglin Hao more than expected).

Fields of papers citing papers by Xianglin Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianglin Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianglin Hao. The network helps show where Xianglin Hao may publish in the future.

Co-authorship network of co-authors of Xianglin Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Xianglin Hao. A scholar is included among the top collaborators of Xianglin Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianglin Hao. Xianglin Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Qian, et al.. (2025). TC2N promotes the proliferation and invasion of head and neck cancer cells with the p53-R175H. Translational Cancer Research. 14(7). 3905–3919.
3.
Hao, Xianglin, Yangfan Lv, Defeng Li, et al.. (2024). TC2N inhibits distant metastasis and stemness of breast cancer via blocking fatty acid synthesis. Journal of Translational Medicine. 22(1). 6–6. 5 indexed citations
4.
Bai, Fuhai, et al.. (2023). Depletion of PIEZO1 expression is accompanied by upregulating p53 signaling in mice with perioperative neurocognitive disorder. Functional & Integrative Genomics. 23(4). 327–327. 1 indexed citations
5.
6.
Bai, Fuhai, Lu Huang, Jiao Deng, et al.. (2023). Prelimbic area to lateral hypothalamus circuit drives social aggression. iScience. 26(10). 107718–107718. 7 indexed citations
7.
Gu, Jing, Xianglin Hao, Jianping Chen, et al.. (2023). TC2N Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Targeting the Wnt/β-Catenin Signaling Pathway. Laboratory Investigation. 103(12). 100260–100260. 8 indexed citations
8.
9.
Han, Fei, Li Yin, Xiao Jiang, et al.. (2021). Identification of SRY‐box 30 as an age‐related essential gatekeeper for male germ‐cell meiosis and differentiation. Aging Cell. 20(5). e13343–e13343. 4 indexed citations
10.
Hao, Xianglin, Liyun Gao, Ning Zhang, et al.. (2019). Tac2-N acts as a novel oncogene and promotes tumor metastasis via activation of NF-κB signaling in lung cancer. Journal of Experimental & Clinical Cancer Research. 38(1). 319–319. 17 indexed citations
11.
Hao, Xianglin, Zhen Tian, Fei Han, et al.. (2019). Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma. Pathology - Research and Practice. 215(7). 152438–152438. 22 indexed citations
12.
Hao, Xianglin, Liyun Gao, Fei Han, et al.. (2019). Identification of TC2N as a novel promising suppressor of PI3K-AKT signaling in breast cancer. Cell Death and Disease. 10(6). 424–424. 16 indexed citations
13.
Han, Fei, Wenbin Liu, Jian‐Jun Li, et al.. (2019). SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer. Endocrine Related Cancer. 26(3). 303–319. 13 indexed citations
14.
Han, Fei, Wenbin Liu, Lei Sun, et al.. (2018). SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients. Respiratory Research. 19(1). 241–241. 24 indexed citations
15.
Hao, Xianglin, Fei Han, Ning Zhang, et al.. (2018). TC2N, a novel oncogene, accelerates tumor progression by suppressing p53 signaling pathway in lung cancer. Cell Death and Differentiation. 26(7). 1235–1250. 38 indexed citations
16.
Hao, Xianglin, Fei Han, Ning Zhang, et al.. (2018). SOX30 is a key regulator of desmosomal gene suppressing tumor growth and metastasis in lung adenocarcinoma. Journal of Experimental & Clinical Cancer Research. 37(1). 111–111. 21 indexed citations
17.
18.
Yang, Juntang, Fei Han, Wenbin Liu, et al.. (2017). ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway. Journal of Experimental & Clinical Cancer Research. 36(1). 170–170. 26 indexed citations
19.
Yang, Juntang, Fei Han, Wenbin Liu, et al.. (2017). LHX6, An Independent Prognostic Factor, Inhibits Lung Adenocarcinoma Progression through Transcriptional Silencing of β-catenin. Journal of Cancer. 8(13). 2561–2574. 13 indexed citations
20.
Huang, Yongsheng, Wenbin Liu, Fei Han, et al.. (2017). Copy number variations and expression of MPDZ are prognostic biomarkers for clear cell renal cell carcinoma. Oncotarget. 8(45). 78713–78725. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akira Nagaoka Breakdown of academic impact, for papers by Julie Di Bernardo Breakdown of academic impact, for papers by Tina Fuglsang Daugaard Breakdown of academic impact, for papers by Yang Cheng Breakdown of academic impact, for papers by Halfdan Rydbeck Breakdown of academic impact, for papers by Cai Lv Breakdown of academic impact, for papers by Simran Arora Breakdown of academic impact, for papers by Joseph Nariculam Breakdown of academic impact, for papers by Iyare Izevbaye Breakdown of academic impact, for papers by Yong Qiu Doughman
Rankless by CCL
2026